Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L.D. Mayer
Observed names:
L D Mayer,
L MAYER,
L Mayer,
L. D. Mayer,
L. Mayer,
LD Mayer,
Lawrence D. Mayer
show all 7
Institution:
Celator Pharmaceuticals (Canada)
Observed institutions:
BC Cancer Agency,
University of British Columbia,
Jewish General Hospital,
Celator Pharmaceuticals (Canada),
McGill University
OpenAlex ID:
A5110146267
Vesicles of variable sizes produced by a rapid extrusion procedure
1986
·
L.D. Mayer
, M.J. Hope
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
1,703
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles
1985
·
L.D. Mayer
, M.J. Hope
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
438
Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol)
2002
·
C. Allen
, N. Dos Santos
, et al.
·
Bioscience Reports
·
398
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
1986
·
L.D. Mayer
, M.B. Bally
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
382
Generation of multilamellar and unilamellar phospholipid vesicles
1986
·
M.J. Hope
, M.B. Bally
, et al.
·
Chemistry and Physics of Lipids
·
360
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models
1995
·
MS Webb
, TO Harasym
, et al.
·
British Journal of Cancer
·
245
PDF
Optimizing Combination Chemotherapy by Controlling Drug Ratios
2007
·
L. D. Mayer
, A. S. Janoff
·
Molecular Interventions
·
216
Liposomal and Nonliposomal Drug Pharmacokinetics after Administration of Liposome-Encapsulated Vincristine and Their Contribution to Drug Tissue Distribution Properties
2001
·
Rajesh Krishna
, Murray S. Webb
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
129
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
1994
·
N L Boman
, D Masin
, et al.
·
PubMed
·
126
Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin
1989
·
J.A.E. Balazsovits
, L.D. Mayer
, et al.
·
Cancer Chemotherapy and Pharmacology
·
120
Phase I Study of Liposomal Vincristine
1999
·
K. A. Gelmon
, A. Tolcher
, et al.
·
Journal of Clinical Oncology
·
108
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
2012
·
E.J. Feldman
, J.E. Kolitz
, et al.
·
Leukemia Research
·
102
Generating and loading of liposomal systems for drug-delivery applications
1989
·
P.R. Cullis
, L.D. Mayer
, et al.
·
Advanced Drug Delivery Reviews
·
98
Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
2000
·
D E Lopes de Menezes
, N Hudon
, et al.
·
PubMed
·
93
Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor
1990
·
L.D. Mayer
, M.B. Bally
, et al.
·
Cancer Letters
·
89
Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes
2005
·
M SANDSTROM
, L ICKENSTEIN
, et al.
·
Journal of Controlled Release
·
80
Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
1997
·
R Krishna
, L D Mayer
·
PubMed
·
78
Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs.
1993
·
P M Kanter
, G A Bullard
, et al.
·
PubMed
·
63
Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients
1989
·
T.E. Redelmeier
, L.D. Mayer
, et al.
·
Biophysical Journal
·
42
PDF
Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential.
1985
·
L D Mayer
, M B Bally
, et al.
·
Journal of Biological Chemistry
·
41
Doxorubicin encapsulated in sterically stabilized liposomes exhibits renal and biliary clearance properties that are independent of valspodar (PSC 833) under conditions that significantly inhibit nonencapsulated drug excretion.
1999
·
R Krishna
, N McIntosh
, et al.
·
PubMed
·
32
The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
1999
·
R Krishna
, L D Mayer
·
PubMed
·
28
Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1
2002
·
T Denyssevych
, VS Lestou
, et al.
·
Leukemia
·
10
Phase 1 study of CPX-1, a fixed ratio formulation of irinotecan (IRI) and floxuridine (FLOX), in patients with advanced solid tumors
2006
·
G. Batist
, K. Chi
, et al.
·
Journal of Clinical Oncology
·
8
Ratiometric dosing of irinotecan (IRI) and floxuridine (FLOX) in a phase I trial: A new approach for enhancing the activity of combination chemotherapy
2007
·
G. Batist
, W. Miller
, et al.
·
Journal of Clinical Oncology
·
5
Show more works
View as search
Works count:
31
Citation count:
5,007
H-index:
22
I10-index:
23
Year
Topic
Type
